Академический Документы
Профессиональный Документы
Культура Документы
Page 2 of 10
Contents
Invitation to participate: ............................................................................................................ 4
Participation: ............................................................................................................................... 4
Your participation is co-ordinated by: ...................................................................................... 5
For more information please contact the network coordinator: .................................................... 5
Message from the Chief Investigator:....................................................................................... 5
Project Management .................................................................................................................. 5
Study Document Translations ................................................................................................... 6
SPRINT-SARI Site Packs.............................................................................................................. 6
Site Packs include:....................................................................................................................... 6
Southern Hemisphere and Tropical region study periods ...................................................... 6
Saudi SPRINT SARI NEWS LETTER AUG 2016
Page 3 of 10
Invitation to participate:
SPRINT-SARI (Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection) is an
international, multi-centre, prospective, short period incidence observational study of
patients in participating hospitals and intensive care units (ICUs) with SARI.
On behalf of the SPRINT-SARI Management Committee, The Saudi Critical Care
Society extends an invitation to participate in this landmark study. SPRINT-SARI represents
an important step in preparing the world to conduct time-critical observational research in
the event of a public health emergency. SPRINT-SARI is two things: a short period
incidence (observational) study that would occur once per year, for a maximum study
period of 7 days, and a process by which ethics approval is obtained to allow SPRINT-SARI
to be activated for a more extended time period in the event of a major outbreak of Severe
Acute Respiratory Infection (SARI
Participation:
The study is being conducted on every continent, in 32 countries (including Saudi Arabia),
across 32 research and hospital networks, in over 240 ICUs and hospitals either
participated, ready to participate or preparing to participate in 2016 (figure 1).
The Northern hemisphere commenced the 5-to-7-day week enrolment period in January 2016. To
date 47 sites have contributed data with 296 individual participants enrolled into SPRINT-SARI
Page 4 of 10
grant from the Australian National Health and Medical Research Council, which allowed Genevieve
ONeill to support the study as its Project Manager, was pivotal in getting SPRINT SARI up and
running. I was the initial chair of the Working Group and Id like to thank all the members of the
Working Group and Management Committee who have been instrumental in developing the
protocol, CRF, and recruiting so many networks and sites. In March this year, Srin Murthy took over
as the Working Group chair. Srin is based in Vancouver and is young and energetic and I know he
will provide fabulous leadership to the study. I will continue to be a member of the Working Group
and I look forward to assisting Srin drive the next stage of evolution of the study.
-Steve Webb
Project Management
SPRINT-SARI has a new full time Project Manager. Dr Maya George (bio here) has taken over the
central project management at Monash University. Dr George is available to answer any questions
you have regarding SPRINT-SARI via the SPRINT-SARI email address.
Central Program Manager: mnhs-sprint.sari@monash.edu
Page 5 of 10
SRPINT-SARI Website
The SPRINT-SARI Website has a new TOOLBOX. The SPRINT-SARI Tool Box offers free access to
research tools and templates that have been shared by other groups, for you to adapt to suit your
Page 6 of 10
site and context. To share your own templates or tools, or to comment on the tools available in this
Tool Box, please email the SPRINT-SARI central Project Manager.
Meanwhile, we encourage feedback from networks and sites regarding issues in CRFs, study
protocol and the data management system that needs to be addressed in our upcoming revisions.
(Please email the SPRINT-SARI Central Project Manager)
Denominator Sub-Study
The objective of the SPRINT-SARI Denominator Study, is to collect aggregate information about
the participating hospitals, and the population that they serve, to develop and validate models that
allow extrapolation from data collected in SPRINT-SARI to the whole-of-population level. The
validation component is possible because in some regions all hospitals within a defined region are
participating in the study.
The significance of the study is that, while SPRINT SARI would be useful during an epidemic or
Page 7 of 10
pandemic to report the descriptive epidemiology of affected patients, the Denominator Study
would be useful in understanding the true population level burden of disease.
This sub-study will allow for model generation to determine the population-level burden of
hospitalized and critically ill patients with SARI, without the need to collect data at all hospitals.
Through the denominator study we aim to:
1. Develop models for extrapolation from local data to the whole-of-population level and
validate models in specific regions where all sites are participating in SPRINT SARI.
2. Extrapolate endemic SARI severe disease burden in participating locations and explore
relationships between estimated whole-of-population disease burden and factors such as
gross national income, geography and size;
The study will also enable SPRINT-SARI to achieve its secondary aims, specifically aims 1 and 8:
1. To understand the incidence of SARI; and
8. Explore the feasibility of extrapolating results obtained at participating sites to population
levels.
Monash University Human Research Ethics Committee (MUHREC) has given approval to conduct
this Sub-Study. Networks and Sites will be contacted soon with information on how to participate.
Page 8 of 10
SPRINT-SARI Presentations
SPRINT-SARI will be presenting at the Options IX conference being held at Chicago U.S.A from 2428 Aug 2016. The presentation will acknowledge individual site contribution through group
authorship as SPRINT-SARI Investigators. If you would like to receive a copy of the abstract or
would like to opt-out from contributing your site data please email the SPRINT-SARI Chief
Investigator
The SPRINT-SARI working group has been applying to small funding opportunities to help support
the ongoing central coordination of the study.
SPRINT-SARI funding opportunities come up frequently but due to the nature of SPRINT-SARI it
difficult to secure funding centrally for all sites and networks. As a result, the SPRINT-SARI working
group is in the process of drafting a generic grant application. This generic grant application
consistence of modules which can be re-shaped to meet specific grant application requirements. It
is the objective of the SPRINT-SARI Management Committee to secure more stable and sustainable
funding with the desire for per patient payment in low and middle income countries. The generic
grant application will provide a template for Networks / Local Groups to re-shape the draft to
enable them to apply for local funding opportunities to support their site participation and
coordination.
Page 9 of 10
Feedback:
The SPRINT-SARI Working Group is asking all site and Networks to provide us with feedback on
ways we can improve the Case Record Form, Protocol and Central Database. If you have any
feedback, please contact the SPRINT-SARI Central Project Manager via email by 1st October 2016.
and emerging Infection Consortium (ISARIC), the Platform for European Preparedness Against (Re-)
emerging Epidemics (PREPARE), and the European Society of Intensive Care Medicine (ESICM).
Copyright *2016*
*SPRINT-SARI*, All rights reserved.
Page 10 of 10